Moderna
MRNA
#1630
Rank
A$16.05 B
Marketcap
$41.53
Share price
-2.41%
Change (1 day)
-73.25%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2024 : A$23.39 Billion

According to Moderna 's latest financial reports the company's total assets are A$23.39 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2024-12-31A$22.73 B-15.93%
2023-12-31A$27.04 B-28.82%
2022-12-31A$37.99 B11.67%
2021-12-31A$34.02 B256.61%
2020-12-31A$9.54 B320.32%
2019-12-31A$2.27 B-18.49%
2018-12-31A$2.78 B100.51%
2017-12-31A$1.38 B-29.34%
2016-12-31A$1.96 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$0.13 B-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$193.69 B 728.07%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.28 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.01 B-70.02%๐Ÿ‡บ๐Ÿ‡ธ USA
A$169.11 B 623.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$1.67 B-92.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$297.89 B 1,173.54%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA